Asthma Severity and Therapy Monitoring by Acoustics (ASThMA)

Phase 1

Completed

• Conditions: Asthma; Respiratory - Asthma

• Registration Number: ACTRN12607000400460
• Lead Sponsor: PulmoSonix Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-08-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Three groups of patients will be invited to participate and we aim to include between six and ten subjects in each group:1. Those with asthma, who are clinically stable with known bronchodilator reversibility on the basis of previous spirometric testing and who use inhaled Salbutamol as required.2. Those undergoing bronchial provocation testing as part of their current clinical care.Inpatients of the Alfred Hospital with an admission diagnosis of an exacerbation of asthma.3. All patients must be able to give informed consent.

Exclusion Criteria

1. Skin problems that preclude placement of the sensors with an adhesive 2. Life-threatening condition with the patient's condition being considered unstable or critical by the attending physician.3. Patient who cannot read and understand the informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A correlation between airway narrowing, sound attenuation and wheeze detection. [At time of presentation to the hospital (single day trial with no extended follow-up).]

Secondary Outcome Measures

Name	Time	Method
Development of a Asthma Severity Index[At time of presentation to the hospital (single day trial with no extended follow-up).]